Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
CARDIOLOGY / EXPERIMENTAL RESEARCH
Protective effect of casticin in myocardial ischemia/reperfusion injury in rats via attenuation of oxidative stress and inflammation
1
Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun,
China
2
Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun,
China
3
Department of Geriatric Medicine, China-Japan Union Hospital of Jilin University,
Changchun, China
Submission date: 2020-07-06
Final revision date: 2020-09-03
Acceptance date: 2020-09-17
Online publication date: 2021-05-09
Publication date: 2026-08-28
Corresponding author
Min Liu
Department of Geriatric Medicine China-Japan Union Hospital of Jilin University 130033, Changchun, China
Department of Geriatric Medicine China-Japan Union Hospital of Jilin University 130033, Changchun, China
Arch Med Sci 2026;22(4):2425-2433
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Myocardial ischemic/reperfusion injury is the main prognostic factor after myocardial infarction. However, by the time reperfusion is achieved, the cardiac tissues have already undergone necrosis and initiated inflammation and oxidative stress. Therefore, the present study aimed to evaluate the beneficial effect of casticin (CST) on myocardial ischemia/ reperfusion (MI/R) injury and to explore its mechanism of action.
Material and methods:
MI/R injury was induced using 30-min left anterior descending coronary artery (LAD) occlusion followed by 4 h reperfusion. CST was administered to rats before reperfusion. The outcome of CST was determined according to various indices of oxidative stress, inflammation, apoptotic genes and nuclear factor k-light-chain-enhancer of activated B cells (NF-kB).
Results:
The results suggested that CST causes significant improvement in left ventricular systolic pressure (LVSP) and derivative of pressure over time of maximal rate of rise of (usually) left ventricular pressure (± dp/dtmax) with reduction of left ventricular end-diastolic pressure (LVEDP). It also reduces increased ST segment together with restoration of the changes in RR interval and QRS complex. The histopathological analysis of cardiac tissue further corroborated the effect of CST. It also causes improvement of the antioxidant system by reducing malondialdehyde (MDA) level with increase in superoxide dismutase (SOD) and glutathione peroxidase (GPx). The levels of cytokines (TNF-α, IL-1β and IL-6) were also found to be reduced upon CST treatment. The expression of NF-kB, inducible nitric oxide synthase (iNOS) and BCL2-associated X protein (Bax) was found to be reduced in the CST treated group together with an increase in Bcl-2.
Conclusions:
Collectively, the results of the study demonstrated that casticin protects rats from MI/R damage possibly via attenuation of oxidative stress, the inflammatory response and apoptosis. It was also shown to inhibit NF-kB and iNOS in western blot analysis.
Myocardial ischemic/reperfusion injury is the main prognostic factor after myocardial infarction. However, by the time reperfusion is achieved, the cardiac tissues have already undergone necrosis and initiated inflammation and oxidative stress. Therefore, the present study aimed to evaluate the beneficial effect of casticin (CST) on myocardial ischemia/ reperfusion (MI/R) injury and to explore its mechanism of action.
Material and methods:
MI/R injury was induced using 30-min left anterior descending coronary artery (LAD) occlusion followed by 4 h reperfusion. CST was administered to rats before reperfusion. The outcome of CST was determined according to various indices of oxidative stress, inflammation, apoptotic genes and nuclear factor k-light-chain-enhancer of activated B cells (NF-kB).
Results:
The results suggested that CST causes significant improvement in left ventricular systolic pressure (LVSP) and derivative of pressure over time of maximal rate of rise of (usually) left ventricular pressure (± dp/dtmax) with reduction of left ventricular end-diastolic pressure (LVEDP). It also reduces increased ST segment together with restoration of the changes in RR interval and QRS complex. The histopathological analysis of cardiac tissue further corroborated the effect of CST. It also causes improvement of the antioxidant system by reducing malondialdehyde (MDA) level with increase in superoxide dismutase (SOD) and glutathione peroxidase (GPx). The levels of cytokines (TNF-α, IL-1β and IL-6) were also found to be reduced upon CST treatment. The expression of NF-kB, inducible nitric oxide synthase (iNOS) and BCL2-associated X protein (Bax) was found to be reduced in the CST treated group together with an increase in Bcl-2.
Conclusions:
Collectively, the results of the study demonstrated that casticin protects rats from MI/R damage possibly via attenuation of oxidative stress, the inflammatory response and apoptosis. It was also shown to inhibit NF-kB and iNOS in western blot analysis.
REFERENCES (50)
1.
Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet 2017; 389: 197-210.
2.
Chen WW, Gao RL, Liu LS, et al. China cardiovascular diseases report 2015: a summary. J Geriatr Cardiol 2017; 14: 1-10.
3.
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013; 123: 92-100.
4.
Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 2005; 14: 170-5.
5.
Jennings RB. Historical perspective on the pathology of myocardial ischemia/reperfusion injury. Circ Res 2013; 113: 428-38.
6.
Zahid H, Rizwani GH, Ishaqe S. Phytopharmacological review on vitex agnus-castus: a potential medicinal plant. Chinese Herb Med 2016; 8: 24-9.
7.
Chan EWC, Wong SK, Chan HT. Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties. J Integr Med 2018; 16: 147-52.
8.
Chen SN, Friesen JB, Webster D, et al. Phytoconstituents from Vitex agnus-castus fruits. Fitoterapia 2011; 82: 528-33.
9.
Liou CJ, Bin Len W, Wu SJ, Lin CF, Wu XL, Huang WC. Casticin inhibits COX-2 and iNOS expression via suppression of NF-B and MAPK signaling in lipopolysaccharide-stimulated mouse macrophages. J Ethnopharmacol 2014; 158 Pt A: 310-6.
10.
Sampath PD, Vijayaraghavan K. Cardioprotective effect of -mangostin, a xanthone derivative from Mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2007; 21: 336-9.
11.
Yousefi K, Fathiazad F, Soraya H, Rameshrad M, Maleki-Dizaji N, Garjani A. Marrubium vulgare L. methanolic extract inhibits inflammatory response and prevents cardiomyocyte fibrosis in isoproterenol-induced acute myocardial infarction in rats. Bioimpacts 2014; 4: 21-7.
12.
Nagoor Meeran MF, Jagadeesh GS, Selvaraj P. Thymol attenuates inflammation in isoproterenol induced myocardial infarcted rats by inhibiting the release of lysosomal enzymes and downregulating the expressions of proinflammatory cytokines. Eur J Pharmacol 2015; 754: 153-61.
13.
Yang J, Wang HX, Zhang YJ, et al. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-kB signaling pathway in isoproterenol-induced myocardial hypertrophy. J Ethnopharmacol 2013; 150: 1062-70.
14.
Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 2020; 17: 773-89.
15.
Frank A, Bonney M, Bonney S, Weitzel L, Koeppen M, Eckle T. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth 2012; 16: 123-32.
16.
Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 2009; 15: RA209-19.
17.
Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med 2010; 48: 1121-32.
18.
Kurian GA, Rajagopal R, Vedantham S, Rajesh M. The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited. Oxid Med Cell Longev 2016; 2016: 1656450.
19.
Hashmi S, Al-Salam S. Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison. Int J Clin Exp Pathol 2015; 8: 8786-96.
20.
Gottlieb RA. Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 2011; 16: 233-8.
21.
Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-8.
22.
Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Hear Circ Physiol 2011; 301: 2181-90.
23.
Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-73.
24.
Mei Y, Thompson MD, Cohen RA, Tong XY. Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta 2015; 1852: 243-51.
25.
Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 2010; 12: 135-42.
26.
Wang TY, AlJaroudi WA, Newby LK. Markers of cardiac ischemia and inflammation. Cardiol Clin 2005; 23:491-501.
27.
Burke AP, Virmani R. Pathophysiology of acute myocardial infarction. Med Clin North Am 2007; 91: 553-72.
28.
Entman ML, Michael L, Rossen RD, et al. Inflammation in the course of early myocardial ischemia. FASEB J 1991; 5: 2529-37.
29.
Rohrbach S, Troidl C, Hamm C, Schulz R. Ischemia and reperfusion related myocardial inflammation: a network of cells and mediators targeting the cardiomyocyte. IUBMB Life 2015; 67: 110-9.
30.
Bartekova M, Radosinska J, Jelemensky M, Dhalla NS. Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev 2018; 23: 733-58.
31.
Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol 2010; 106: 360-8.
32.
Paoletti R, Gotto AM, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation 2004; 109 (23 Suppl 1): III20-6.
33.
Yoo SY, Kwon SM. Angiogenesis and its therapeutic opportunities. Mediators Inflamm 2013; 2013: 127170.
34.
Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM, Woodruff TM. Toll-like receptors in ischemia-reperfusion injury. Shock 2009; 32: 4-16.
35.
Liu T, Zhang L, Joo D, Sun SC. NF-B signaling in inflammation. Signal Transduct Target Ther 2017; 2: 17023.
36.
Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 2012; 4: a006049.
37.
Lawrence T. The nuclear factor NF-kappa B pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 6: a001651.
38.
Ghosh S, Hayden MS. New regulators of NF-B in inflammation. Nat Rev Immunol 2008; 8: 837-48.
39.
Sun SC. The non-canonical NF-B pathway in immunity and inflammation. Nat Rev Immunol 2017; 17: 545-58.
40.
Rahman A, Fazal F. Blocking NF-kB: an inflammatory issue. Proc Am Thorac Soc 2011; 8: 497-503.
41.
Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 471-9.
42.
Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 2005; 15: 277-89.
43.
Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000; 60: 184-90.
44.
Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase – time for reappraisal. Curr Drug Targets Inflamm Allergy 2002; 1: 89-108.
45.
Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 2002; 55: 438-55.
46.
Freude B, Masters TN, Robicsek F, et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 2000; 32: 197-208.
47.
Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci USA 2002; 99: 12825-30.
48.
Eken MK, Ersoy GS, Kaygusuz EI, et al. Etanercept protects ovarian reserve against ischemia/reperfusion injury in a rat model. Arch Med Sci 2019; 15: 1104-12.
49.
Sedaghat Z, Kadkhodaee M, Seifi B, Salehi E. Inducible and endothelial nitric oxide synthase distribution and expression with hind limb per-conditioning of the rat kidney. Arch Med Sci 2019; 15: 1081-91.
50.
Anselmi A, Abbate A, Girola F, et al. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg 2004; 25: 304-11.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
